When it comes to managing active pharmaceutical ingredients (APIs), hormonal agents, or toxic substances, safety is paramount. That’s why DOTT. BONAPACE & C. has developed the IN-CAP WIP ISOLATED, an advanced containment system engineered to provide the highest level of protection for both operators and the environment. With containment levels up to OEB 5, this cutting-edge isolated system ensures unmatched safety without compromising performance.

The IN-CAP WIP ISOLATED is more than just a containment solution—it delivers peace of mind. Fully compliant with GMP and FDA regulations, it guarantees a clean, safe, and efficient work environment. Whether integrated with the IN-CAP WIP or the CPR-18 WIP, this isolator system is designed to meet the toughest challenges in pharmaceutical production.

Key Features of the IN-CAP WIP ISOLATED Containment System:

• High-Quality Construction for Strength and Hygiene

  • Fabricated from AISI 316L stainless steel for durability.
  • Internal surfaces polished to a smooth Ra < 0.50 μm for easy cleaning.
  • External surfaces finished to Ra < 0.80 μm for enhanced durability.

• Enhanced Accessibility and Safety

  • Equipped with three doors for easy operator access.
  • Includes two pairs of robust gloves made from Neoprene/EPDM/CSM, ensuring secure material handling.

• Advanced Airflow and Containment Technology

  • Features a state-of-the-art laminar airflow system for particle-free operations.
  • Achieves a containment performance target (CPT) of <1 μg/m³ (8h TWA), meeting strict OEB 5 standards.

With the IN-CAP WIP ISOLATED, pharmaceutical manufacturers can trust in a system that combines superior containment technology with precision-engineered safety, protecting both personnel and processes.